ASX: ACW - Xanamem Clinical Development & Investor Update.

Tuesday, July 2, 2019 10:00 PM +00:00

ASX: ACW - Xanamem Clinical Development & Inv...0:0010:09
LIVEQuality1  AudioSubtitleDownloadSpeed1  
ACTINOGEN LIMITED
Bill Ketelbey

Actinogen Medical (ASX: ACW) is pleased to provide an update on the progress the Company is making with the ongoing clinical development program for Xanamem™. This update should be read in conjunction with the latest investor presentation.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 16 Mar

    02:00

    Investor Day 13 March 2020

    ILLINOIS TOOL WORKS INC
  • 18 Mar

    00:30

    Q4 2019 Baxter International Inc. Earnings Conference Call March 17, 2020

    BAXTER INTERNATIONAL INC
  • 18 Mar

    01:00

    FY20 Half Year Results 17 March 2020

    FERGUSON
  • 18 Mar

    01:30

    2019 Full Year Results Presentation 17 March 2020

    ANTOFAGASTA PLC
  • 18 Mar

    09:30

    FedEx Q3 FY20 Earnings Call 17 March 2020

    FEDEX CORPORATION